---
title: "H\u0026R GMBH \u0026 CO. KGAA Half-Year Report Germany; Guidance exceeded, EBITDA above €100m"
sdDatePublished: "2026-08-14T15:35:00Z"
source: "https://www.hur.com/fileadmin/user_upload/media/Berichte_IR/2026/HuR_IR2_2026.pdf"
topics:
  - name: "corporate earnings"
    identifier: "medtop:20000178"
  - name: "financial statement"
    identifier: "medtop:20000180"
  - name: "oil and gas"
    identifier: "medtop:20001243"
  - name: "international trade"
    identifier: "medtop:20000373"
  - name: "logistics"
    identifier: "medtop:20001170"
locations:
  - "Quickborn"
  - "Salzbergen"
  - "Coburg"
  - "Hamburg"
  - "Iran"
  - "China"
  - "United States"
  - "Israel"
  - "Czech Republic"
  - "Ireland"
  - "Germany"
---


H&R GMBH & CO. KGAA Half-Year Report Germany; Guidance exceeded, EBITDA above €100m

HALF-YEAR-
REPORT
of H&R GmbH & Co. KGaA
AS OF
June 30,
2026

2
H&R GMBH & CO. KGAA
Half-Year Report

Our First Six Months of 2026
– Sales revenues reach €700.4 million
– EBITDA of €84.4 million reaches full-year 2026 guidance by mid-year
– Significant earnings momentum in Q2 2026 driven by developments in Persian Gulf
H&R GMBH & CO. KGAA IN FIGURES
IN € MILLION
1/1-6/30/2026
1/1-6/30/2025
Change
(absolute)
Sales revenue
700.4
653.1
47.3
Operating income (EBITDA)*
84.4
40.1
44.3
EBIT
59.4
10.9
48.5
EBT
53.5
4.9
48.6
Consolidated net income
44.5
1.2
43.3
Consolidated income attributable to shareholders
41.6
0.3
41.3
Consolidated income per share (undiluted) in €
1.12
0.01
1.11
Cash flow from operating activities
2.4
24.6
-22.2
Cash flow from investing activities
-22.0
-19.5
-2.5
Free cash flow
-19.5
5.1
-24.6
Cash flow from financing activities
17.3
-1.8
19.1

6/30/2026
12/31/2025
Change
(absolute)
Balance sheet total
1,033.9
916.2
117.7
Net working capital
253.5
159.6
93.9
Equity
471.4
416.1
55.3
Equity ratio (in %)
45.6
45.4
0.2
No. of employees
1,688
1,714
-26

 THE SEGMENTS IN FIGURES
IN. € MILLION
1/1-6/30/2026
1/1-6/30/2025
Change
(absolut)
Chemical Pharmaceutical Raw Material Refining

Sales revenue
445.9
405.9
40.0
EBITDA
62.1
26.9
35.2
Chemical Pharmaceutical Raw Materials Sales

Sales revenue
246.3
237.1
9.2
EBITDA
25.7
17.8
7.9
Plastics

Sales revenue
16.0
18.9
-2.9
EBITDA
-1.7
-1.9
0.2
Reconciliation

Sales revenue
-7.8
-8.7
0.9
EBITDA
-1.8
-2.7
0.9
* EBITDA – consolidated income before income taxes, other financial income and expenses, depreciation, amortization and
impairment, and appreciation of fixed assets and property, plant and equipment.

3

Letter from the Executive Board
Dear Shareholders,
Dear Business Partners,

After an overall operational fairly solid final quarter of 2025, the Company entered fiscal year 2026 on a
rather subdued note. This changed when the outbreak of war between the United States and Israel on one side
and Iran on the other introduced yet another major source of uncertainty for the global economy and disrupted
international trade structures.
When hostilities began toward the end of the first quarter, neither the impact nor the duration of the conflict
could be assessed reliably by companies. Only the crude oil price reacted immediately, directly driving up
fuel prices as well. The prices of our feedstocks also increased, although only a small portion of the crude oil
processed in Europe has originated from the Gulf region for many years.
The weeks that followed demonstrated that the economic effects of the current conflict in the Gulf region
could also affect us in Germany significantly, albeit in different ways, due to the regional distribution of
industries, agricultural land, and logistics infrastructure. For example, because of the blockade of the Strait
of Hormuz, Northern Europe is now facing shortages of large quantities of fertilizers and raw materials for
the chemical industry. Ships of large Hamburg shipping companies are stranded in the Gulf region, one of
the world's most important logistics and transportation hubs. Supply chains to and from Asia that route
through the region are suffering severe disruption.
Assessing our own opportunities in such an environment and communicating them with a reasonable degree
of confidence to shareholders, customers, and business partners is no easy task. Ultimately, after several
months of back-and-forth marked by both confrontational and diplomatic statements from the U.S. President,
we decided in mid-May to maintain our guidance of EUR 85 million to EUR 100 million.
Following the publication of our insider information regarding the course of the second quarter and the release
of our preliminary figures as of June 30, this is no longer a secret: this forecast is expected to be exceeded,
most likely even beyond the upper end of the range. How is it that our Company is able to benefit so unex-
pectedly from the current situation?
Upon closer examination, we find ourselves in a situation similar to that experienced during the COVID-19
pandemic, albeit under completely different circumstances. In 2020/21, much of the travel, aviation, and pas-
senger transportation sectors came to a standstill during the lockdowns. Demand for fuels declined, and lub-
ricant refineries reduced production. H&R's specialty production sites, however, took residue of still produc-
ing fuel refineries in and remained operational and capable of supplying customers.
Today, high crude oil prices are leading to increased fuel prices amid continued strong demand. Rather than
directing residual materials to lubricant refineries, major oil companies are further processing them through
crackers for fuel production. Base oil capacities are being reduced. In this scenario as well, H&R remains
ready to purchase feedstocks, maintain production, and ensure reliable customer supply.
As a result, by the halfway point of 2026 we have already approached our original EBITDA expectation for
the entire year. At EUR 62.5 million, second-quarter 2026 EBITDA exceeded the prior-year quarter's figure
of EUR 17.8 million. Driven largely by this performance, operating earnings for the first half of the year
reached EUR 84.4 million, surpassing the previous year's six-month figure by EUR 44.3 million. In addition
to our ability to supply customers and strong customer demand, this performance was primarily attributable
to exceptionally favorable pricing for particularly sought-after product groups. With personnel expenses re-
maining broadly comparable and depreciation declining, our other earnings levels also recovered. Net income
attributable to shareholders amounted to EUR 41.6 million (H1 2025: EUR 0.3 million). By the end of the

4
H&R GMBH & CO. KGAA
Half-Year Report

first half, higher feedstock costs in the second quarter, which were passed on to customers, increased sales
revenues to EUR 700.4 million (H1 2025: EUR 653.1 million).
Earnings per share of EUR 1.12 are highly encouraging.
Nevertheless, it remains important after two weak years to strengthen our financial buffers for the tasks and
challenges ahead. For H&R, it remains to be seen whether this can be achieved and how the coming months
will develop, as well as what implications these developments may bring. Given the constantly changing news
environment, a rapid resolution of the conflict does not appear likely. Much like the war in Ukraine, the
conflict between the United States and Iran appears to be resisting any plan for an “end on day one.”
Although we are seeing the first signs of moderating demand, we remain confident and intend to continue
taking advantage of the current opportunities for some time. Based on our current knowledge, we now expect
our guidance for operating earnings to fall within a range of EUR 120.0 million to EUR 145.0 million.
We thank you for your continued support and, above all: stay optimistic and stay healthy!
Hamburg, August 2026
Sincerely yours,

Niels H. Hansen
Managing Director

5

Interim Consolidated
Management Report
of H&R GmbH & Co. KGaA
6
Group Structure
7
Subscribed Capital and
Shareholder Structure
8
Economic Environment
11
Share and Share Price
Trend
12
Net Assets, Financial Po-
sition and Results of Op-
erations
17
Report on Opportunities
and Risks
17
Key Events Following the
Reporting Date
18
Outlook

6
H&R GMBH & CO. KGAA
HALF-YEAR REPORT 2026

Group Structure
Sectors and Organizational Structure
The H&R Group organizes its operating activities
into two business divisions: Chemical-Pharmaceuti-
cal Raw Materials and Plastics.
Our ChemPharm Refining segment includes the two
German specialty production sites in Hamburg and
Salzbergen. We operate these sites with the aim of
achieving as high a percentage as possible of output
consisting of hydrocarbon-based specialty products
such as label-free plasticizers, paraffins and white
oils.
During the course of our production processes, we
create approximately 800 different products that are
used in almost every area of life.
Our ChemPharm Sales segment is comprised of nu-
merous plants for additional processing as well as
our distribution sites worldwide.
In the Plastics segment, we manufacture our preci-
sion plastic parts at our locations in Coburg, Czech
Republic and China. The customers buying our Plas-
tics products include the automotive industry, the
medical technology industry and other traditional in-
dustrial sectors.
Group’s Legal Structure
As the Group’s holding company, H&R GmbH &
Co. KGaA (hereinafter referred to as H&R) is in
charge of the management of our business opera-
tions. The holding company is responsible for the
company’s strategic focus, manages the Group’s fi-
nancing activities and provides various management
functions and services for our subsidiaries.
At the end of the reporting period, there were 49 con-
solidated subsidiaries (December 31, 2025: 49). Our
subsidiaries can be found in the list of shareholdings
in the Notes to the Consolidated Financial State-
ments in the 2025 Annual Report under “Scope of
Consolidation and Holdings”.
Employees
The number of employees in the H&R Group de-
creased to 1,688 as of June 30, 2026, compared with
the balance sheet date (December 31, 2025: 1,714
employees). Of these, a total of 174 female employ-
ees and 711 male employees were employed in Ger-
many. Internationally, 322 female employees and
481 male employees worked for the Group.
Changes within the business segments were as fol-
lows: In the ChemPharm business, the number of
employees stood at 1,347 during the reporting pe-
riod, compared with 1,354 at year-end (December
31, 2025), representing a decrease of 7 employees.
Of this total, the Refining segment accounted for 746
employees, a reduction of 5 employees compared
with year-end. In the Sales segment, 2 employees left
the company compared with year-end, reducing
headcount to 601 employees. In the Plastics seg-
ment, H&R KGaA employed a total of 16 fewer em-
ployees compared with year-end 2025, bringing the
workforce down to 273 employees.
In the Other Activities segment, a total of 68 employ-
ees were employed as of the half-year reporting date,
representing a decrease of 3 employees compared
with the reporting date.

INTERIM CONSOLIDATED MANAGEMENT REPORT
7
Subscribed Capital and Shareholder Structure

Subscribed Capital and Shareholder Structure
As of June 30, 2026, the subscribed share capital of
H&R
GmbH
&
Co.
KGaA
amounted
to
€95,155,882.68. It was divided into 37,221,746 no-
par-value bearer shares. This corresponded to a no-
tional value of €2.56 per share. There are no different
classes of shares; only ordinary shares are outstand-
ing. Each share carries one voting right.
In an official voting rights notification dated Sep-
tember 30, 2025, Mr. Nils Hansen, Quickborn, re-
ported that, following the completion of the takeover
offer by H&R Holding GmbH and the execution of
the contribution agreement, under which the shares
in H&R GmbH & Co. KGaA held by H&R Holding
GmbH, H&R Internationale Beteiligung GmbH,
Nils Hansen, SRS-Schmierstoff Vertrieb GmbH,
Ölfabrik Wilhelm Scholten GmbH, and Wilhelm
Scholten Beteiligungen GmbH were contributed to
H&R Beteiligung GmbH, his voting rights interest
in the Company amounted to a total of 77.65%.
According to informal voting rights notifications as
of December 31, 2025 and June 30, 2026, additional
shares were acquired between the publication of the
aforementioned voting rights notification and the re-
spective reporting dates. As a result, the voting rights
attributable t